A functional and regulatory network associated with PIP expression in human breast cancer
about
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesQuantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genisteinGCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.Amplification of the prolactin receptor gene in mammary lobular neoplasia.p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells.Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice.p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer.Does germ-line deletion of the PIP gene constitute a widespread risk for cancer?Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.Variation at HLA-DPB1 is associated with dermatomyositis in Chinese population.AZGP1 binds PIP
P2860
Q34006749-AE88B708-0769-46BC-A585-641EB4EF0C3CQ34454890-EE559B7A-A49F-4F4C-964B-66B56D36746CQ35617535-57A02499-9114-44A1-90DA-978B2881C597Q36946554-4D81A620-05B8-4C2E-9397-60C920B98A10Q38415541-3A7570E2-9D97-492C-82F9-A2CC8A920BD3Q39121067-DB98A89F-BCD9-4FF5-8F35-7C702091D7A8Q39175542-ED3BF67C-EB1B-4D0A-A087-AFDDAB13E4DDQ39308784-0429E4DC-08E7-4221-A2B7-2511D2488061Q40164071-B62F9438-FBDB-46C8-9A06-95D563788EE5Q42528982-595D3788-5666-405C-9804-2F82BE230008Q44502455-DC2C8CF9-CEC1-4BB1-9AC7-0EA6FB00528BQ47853979-199C8983-3219-4301-8A95-201798F796C2Q50299697-68B0F084-CCD1-4DF9-92AD-09C565CF4ECD
P2860
A functional and regulatory network associated with PIP expression in human breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A functional and regulatory network associated with PIP expression in human breast cancer
@ast
A functional and regulatory network associated with PIP expression in human breast cancer
@en
A functional and regulatory network associated with PIP expression in human breast cancer
@en-gb
A functional and regulatory network associated with PIP expression in human breast cancer
@nl
type
label
A functional and regulatory network associated with PIP expression in human breast cancer
@ast
A functional and regulatory network associated with PIP expression in human breast cancer
@en
A functional and regulatory network associated with PIP expression in human breast cancer
@en-gb
A functional and regulatory network associated with PIP expression in human breast cancer
@nl
altLabel
A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer
@en
prefLabel
A functional and regulatory network associated with PIP expression in human breast cancer
@ast
A functional and regulatory network associated with PIP expression in human breast cancer
@en
A functional and regulatory network associated with PIP expression in human breast cancer
@en-gb
A functional and regulatory network associated with PIP expression in human breast cancer
@nl
P2093
P2860
P50
P1433
P1476
A functional and regulatory network associated with PIP expression in human breast cancer
@en
P2093
Alessandra Camarca
Dominique Piatier-Tonneau
Eric Eveno
Régine Mariage-Samson
Sandrine El Marhomy
Virginie Boulanger
P2860
P356
10.1371/JOURNAL.PONE.0004696
P407
P577
2009-01-01T00:00:00Z